The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 15,401–15,500 of 31,469
Acanthosis nigricans: a flag for insulin resistance
Venkatswami, S., & Anandam, S. (2014) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2014.11073603 · Cited by 20
Henriksen, E. J., Teachey, M. K., Lindborg, K. A., et al. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00178.2008 · Cited by 20
Brillante, D., O’Sullivan, A., Johnstone, M. T., et al. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00678.x · Cited by 20
Rhee, S. Y., Kwon, M. K., Park, B.-J., Chon, S., Jeong, I., Oh, S., Ahn, K. J., Chung, H. Y., Kim, S. W., Kim, J.-W., et al. (2007) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2007.22.4.270 · Cited by 20
Thomas, G. N., Schooling, C. M., McGhee, S. M., Ho, S. Y., Cheung, B. M. Y., Wat, N. M. S., Janus, E. D., Lam, T. H., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02250 · Cited by 20
Pareyn, A., Allegaert, K., Verhamme, P. B., Vinckx, J., & Casteels, K. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12139 · Cited by 20
Hische, M., Luis-Dominguez, O., Pfeiffer, A. F. H., Schwarz, P. E. H., Selbig, J., & Spranger, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0649 · Cited by 20
Woelfle, J., Roth, C. L., Wunsch, R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0423 · Cited by 20
Niu, Y., YANG, Z. K., Li, X., et al. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0067-5 · Cited by 20
MTHFR 677C/T and 1298A/C mutations and non-alcoholic fatty liver disease
Kasapoğlu, B., Türkay, C., Yalçın, K. S., et al. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-3-248 · Cited by 20
Araújo, T. G., Oliveira, A. G., Vecina, J. F., Marin, R. M., Franco, E. S., Saad, M. J. A., & Maia, M. B. D. S. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.02.048 · Cited by 20
Hugo, M., Mehsen-Cêtre, N., Pierreisnard, A., Schaeverbeke, T., Gin, H., & Rigalleau, V. (2016) · Rheumatology · doi:10.1093/rheumatology/kew038 · Cited by 20
Nassis, G. P., & Sidossis, L. S. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241665.38385.5b · Cited by 20
Hyperprolactinemia induced by hCG leads to metabolic disturbances in female mice
Ratner, L. D., Stevens, G., Bonaventura, M. M., Lux-Lantos, V. A., POUTANEN, M. H., Calandra, R. S., Huhtaniemi, I. T., & Rulli, S. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0528 · Cited by 20
Yang, Y., Liu, Y., Zhang, L., Li, H., Li, X.-B., Ouyang, Q., & Zhu, G. (2015) · PubMed Central · Cited by 20
Yu, T. Y., Jee, J. H., Bae, J. C., Hong, W., Jin, S., Kim, J. H., & Lee, M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.149 · Cited by 20
Sasso, M., Liu, Y., Aron‐Wisnewsky, J., Bouillot, J., Abdennour, M., Clet, M., Sandrin, L., Naour, G. L., Bédossa, P., Tordjman, J., et al. (2016) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2016.06.016 · Cited by 21
GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance
Yalçın, M. M., Altınova, A. E., Aktürk, M., Gülbahar, Ö., Arslan, E., Şendoğan, D. Ö., Yetkin, İ., & Törüner, F. B. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1240843 · Cited by 20
Rijks, J. H. J., Karnebeek, K., van Dijk, J., Dorenbos, E., Gerver, W. M., Stouthart, P. J. H. M., Plat, J., & Vreugdenhil, A. C. E. (2016) · Scientific Reports · doi:10.1038/srep31892 · Cited by 20
Léger‐Guist'hau, J., Domingues-Faria, C., Miolanne, M., Peyrol, F., Gerbaud, L., Perreira, B., Minet‐Quinard, R., Sapin, V., Walrand, S., & Boirie, Y. (2016) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12405 · Cited by 20
Salazar, M. R., Carbajal, H. A., Espeche, W. G., Aizpurúa, M., Marillet, A. G., Sisnieguez, C. E. L., Sisnieguez, B. C. L., Stavile, R. N., March, C., & Reaven, G. M. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000248 · Cited by 20
Bromocriptine and insulin sensitivity in lean and obese subjects
Bahler, L., Verberne, H. J., Brakema, E. A., et al. (2016) · Endocrine Connections · doi:10.1530/ec-16-0051 · Cited by 20
Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassaemia
Chuansumrit, A., Pengpis, P., Mahachoklertwattana, P., Sirachainan, N., Poomthavorn, P., Sungkarat, W., Kadegasem, P., Khlairit, P., & Wongwerawattanakoon, P. (2016) · Acta Haematologica · doi:10.1159/000450673 · Cited by 22
Kebapçılar, L. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/20874.8611 · Cited by 20
Gouaref, I., Détaille, D., Wiernsperger, N. F., Khan, N. A., Leverve, X. M., & Koceir, E.-A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172053 · Cited by 21
Hasan, H. A., Attlee, A., Raigangar, V. L., Madkour, M. I., & Awadallah, S. M. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.012 · Cited by 22
Lima, J. G., Nóbrega, L. H. C., de Lima, N. N., dos Santos, M. C. F., Baracho, M. D. F. P., Winzenrieth, R., Bandeira, F. A. F., Mendes-Aguiar, C. D. O., Neto, F. P. F., Ferreira, L. C., et al. (2017) · Bone · doi:10.1016/j.bone.2017.03.053 · Cited by 20
Pei, L., Yuan, C., Guo, Y., Kou, H., Xia, L., Zhang, L., Yan, Y., Xu, D., & Wang, H. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.06.045 · Cited by 20
Chen, Y., Zhao, Q., Du, G., & Xu, Y. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0512-8 · Cited by 20
Yeo, R., Yoon, S. R., & Kim, O. Y. (2017) · Clinical Nutrition Research · doi:10.7762/cnr.2017.6.3.172 · Cited by 20
de Luis, D. A., Izaola, O., Primo, D., et al. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.06.001 · Cited by 20
Elizalde-Barrera, C. I., Estrada‐García, T., Lozano-Nuevo, J. J., et al. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817732731 · Cited by 20
Seo, D. H., Kim, S. H., Song, J. H., Hong, S., Suh, Y. J., Ahn, S. H., Woo, J., Baik, S. H., Park, Y., Lee, K. W., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0186 · Cited by 20
Asano, M., Kushida, M., Yamamoto, K., Tomata, Y., Tsuji, I., & Tsuduki, T. (2019) · Obesity · doi:10.1002/oby.22448 · Cited by 21
SEWAYBRICKER, L. E., Melhorn, S. J., Askren, M. K., Webb, M. F., Tyagi, V., Leon, M. R. B. D., Grabowski, T. J., Seeley, W. W., & Schur, E. A. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0361-9 · Cited by 20
O’Donovan, S. D., Lenz, M., Vink, R., Roumans, N. J. T., de Kok, T. M. C. M., Mariman, E. C. M., Peeters, R., van Riel, N. A. W., van Baak, M. A., & Arts, I. C. W. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007400 · Cited by 23
Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.
Stengel, J. Z., & Harrison, S. A. (2006) · Europe PMC (PubMed Central) · Cited by 19
Μacut, D., Antić, I. B., Bjekić-Macut, J., Panidis, D., Τζιόμαλος, Κ., Milutinović, D. V., Stanojlović, O. P., Kastratović-Kotlica, B., Petakov, M. S., & Milic, N. M. (2016) · HORMONES · doi:10.1007/bf03401401 · Cited by 20
Wolffenbuttel, B. H. R., Sels, J.-P. J. E., & Huijberts, M. S. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.3.467 · Cited by 20
Bamshad, M. (2005) · JAMA · doi:10.1001/jama.294.8.937 · Cited by 184
Gambineri, A., Pagotto, U., lasio, R. D., Meriggiola, M. C., Costantino, A., Patton, L., Pelusi, C., Pelusi, G., & Pasquali, R. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345380 · Cited by 20
Lee, Y., Kwon, M. K., Kang, E. S., Park, Y. M., Choi, S. H., Ahn, C. W., Kim, K., Park, C. W., Soo, B., Kim, S. W., et al. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1153 · Cited by 19
Thomas, G. N., McGhee, S. M., Schooling, C. M., Ho, S. Y., Lam, K. S. L., Janus, E. D., & Lam, T. H. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.004 · Cited by 20
The case for metabolic hypertension: Is it time to restructure the hypertension paradigm?
Pool, P. E. (1993) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(93)90020-e · Cited by 20
Bain, V. G., Kaita, K., Marotta, P., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.056 · Cited by 20
Jenkins, A. B., Samaras, K., Carey, D., Kelly, P., & Campbell, L. V. (2000) · Twin Research · doi:10.1375/136905200320565427 · Cited by 20
Basaria, S., Muller, D. C., Carducci, M. A., et al. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.6.612 · Cited by 20
Yamada, Y., Sekihara, H., Omura, M., Yanase, T., Takayanagi, R., Mune, T., Yasuda, K., Ishizuka, T., Ueshiba, H., Miyachi, Y., et al. (2007) · Endocrine Journal · doi:10.1507/endocrj.k05-132 · Cited by 20
Mlinar, B., Marc, J., Jensterle, M., Bokal, E. V., Jerin, A., & Pfeifer, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.002 · Cited by 20
Zou, C. C., Huang, K., Liang, L. Y., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03171.x · Cited by 20
Impact of antiretroviral therapy on visfatin and retinol‐binding protein 4 in HIV‐infected subjects
Schindler, K., Haider, D. G., Wolzt, M., Rieger, A., Gmeinhart, B., Luger, A., Nowotny, P., & Ludvik, B. H. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01699.x · Cited by 20
Are saturated fatty acids and insulin resistance associated with fatty liver in obese children?
Papandreou, D., Rousso, I., Malindretos, P., Makedou, A., Moudiou, T., Pidonia, I., Pantoleon, A., Economou, I., & Mavromichalis, I. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2007.11.003 · Cited by 20
Skin microvascular vasodilatory capacity in offspring of two parents with Type 2 diabetes
Lee, B. C., Shore, A. C., Humphreys, J., Lowe, G. D. O., Rumley, A., Clark, P. M. S., Hattersley, A. T., & Tooke, J. E. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00514.x · Cited by 20
Patel, J. V., CASLAKE, M. J., Vyas, A., Cruickshank, J. K., Prabhakaran, D., Bhatnagar, D., Reddy, K. S., Lip, G. Y. H., Mackness, M., Hughes, E. A., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.010 · Cited by 20
SUITO Index for Evaluation of Clinical Islet Transplantation
Takita, M., & Matusmoto, S. (2012) · Cell Transplantation · doi:10.3727/096368912x636885 · Cited by 22
Panidis, D., Μacut, D., Farmakiotis, D., Rousso, D., Kourtis, A., Katsikis, I., Spanos, N., Petakov, M. S., Bjekić, J., & Damjanovic, S. S. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.12.016 · Cited by 20
No Association between rs7566605 Variant and Being Overweight in Japanese
Kuzuya, M., Ando, F., Iguchi, A., & Shimokata, H. (2007) · Obesity · doi:10.1038/oby.2007.301 · Cited by 20
Plasma Thiols and Androgen Levels in Polycystic Ovary Syndrome
Vrbíková, J., Tallová, J., Bičı́ková, M., et al. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.035 · Cited by 20
Effect of Insulin Resistance on Left Ventricular Structural Changes in Hypertensive Patients
Kaftan, H. A., Evrengül, H., Tanriverdi, H. I., & Kılıç, M. (2006) · International Heart Journal · doi:10.1536/ihj.47.391 · Cited by 20
Kinoshita, M., Nakaya, Y., Harada, N., et al. (2002) · Circulation Journal · doi:10.1253/circj.66.655 · Cited by 20
Adalı, E., Yıldızhan, R., Kurdoğlu, M., Buğdaycı, G., Kolusarı, A., & Şahin, H. G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.037 · Cited by 20
Type 2 diabetes mellitus among children and adolescents in Al-Ain: a case series.
Punnose, J., Agarwal, M., & Bin-Uthman, S. (2005) · PubMed · Cited by 18
Tirsi, A., Bruehl, H., Sweat, V., Tsui, W., Reddy, S., Javier, E., Lee, C. M., & Convit, A. J. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.12.046 · Cited by 20
Wolffenbuttel, B. H. R., Weber, R. F. A., van Koetsveld, P. M., Weeks, L., & Verschoor, L. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01220.x · Cited by 20
Satoh, H., Terada, H., Uehara, A., Katoh, H., Matsunaga, M., Yamazaki, K., Matoh, F., & Hayashi, H. (2005) · Heart · doi:10.1136/hrt.2003.032326 · Cited by 20
Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases
Harano, Y., Suzuki, M., Koyama, Y., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00192-1 · Cited by 20
Ohya, M., Taniguchi, A., Fukushima, M., Nakai, Y., Kawasaki, Y., Nagasaka, S., Kuroe, A., Taki, Y., Yoshii, S., Hosokawa, M., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.017 · Cited by 20
Bo, S., Rosato, R., Ciccone, G., Gambino, R., Durazzo, M., Gentile, L., Cassader, M., Cavallo‐Perin, P., & Pagano, G. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.910 · Cited by 20
Seow, K., Juan, C., Ho, L., Hsu, Y.-P., Lin, Y., Huang, L., & Hwang, J. (2007) · Human Reproduction · doi:10.1093/humrep/del489 · Cited by 20
Sleep Apnea and Metabolic Dysfunction
Punjabi, N. M., & Beamer, B. A. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50093-8 · Cited by 20
Shigematsu, Y., Norimatsu, S., Ohtsuka, T., Okayama, H., & Higaki, J. (2006) · Hypertension Research · doi:10.1291/hypres.29.499 · Cited by 20
Toumba, M., Hadjidemetriou, A., Topouzi, M., et al. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.7.677 · Cited by 20
Invitti, C., Gilardini, L., Pontiggia, B., Morabito, F. C., Mazzilli, G., & Viberti, G. C. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.001 · Cited by 20
Okumura, K., Matsui, H., Ogawa, Y., Takahashi, R., Matsubara, K., Imai, H., Imamura, A., Mizuno, T., Tsuzuki, M., & Kitamura, Y. (2003) · Metabolism · doi:10.1053/meta.2003.50056 · Cited by 20
Yung, B., & Hodson, M. E. (1999) · Journal of the Royal Society of Medicine · doi:10.1177/014107689909237s07 · Cited by 20
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
Effects of chromium supplementation on glycogen synthesis after high-intensity exercise
VOLEK, J. S., SILVESTRE, R., KIRWAN, J. P., SHARMAN, M. J., JUDELSON, D. A., SPIERING, B. A., VINGREN, J. L., MARESH, C. M., VANHEEST, J. L., & KRAEMER, W. J. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000235353.09061.54 · Cited by 19
Beavers, K. M., Case, L. D., Blackwell, C. S., Katula, J. A., Goff, D. C., & Vitolins, M. Z. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2014.09.003 · Cited by 19
Very low‐calorie ketogenic diet rapidly augments testosterone levels in non‐diabetic obese subjects
Cignarelli, A., Santi, D., Genchi, V. A., Conte, E., Giordano, F., Di Leo, S., Natalicchio, A., Laviola, L., Giorgino, F., & Perrini, S. (2023) · Andrology · doi:10.1111/andr.13357 · Cited by 19
Wang, G., Watanabe, M., Imai, Y., Hara, K., Manabe, I., Maemura, K., Horikoshi, M., Ozeki, A., Itoh, C., Sugiyama, T., et al. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.101 · Cited by 19
Lima, L. R., Okamura, A. B., de Carvalho, K. M. B., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201240 · Cited by 19
The Effects of Prolonged Water-Only Fasting and Refeeding on Markers of Cardiometabolic Risk
Scharf, E. L., Kolbe, P., Hwang, S.-Y., Thompson, N., Gilbert, M., Alexandrakis, F., Bonjour, M., Zeiler, E., & Myers, T. R. (2022) · Nutrients · doi:10.3390/nu14061183 · Cited by 18
Lee, S.-B., Jin, M. H., & Yoon, J.-H. (2024) · Scientific Reports · doi:10.1038/s41598-024-57380-9 · Cited by 19
Yuan, H., Xu, G., Liu, J., Yan, Y., Zhao, S., Cai, F., Yu, X., Wang, Y., & Li, M. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.05.007 · Cited by 19
Zhong, L. X., Jin, P., Liu, Y., Zhang, Z., Wu, X., Weng, M., Cao, S., Wang, Y., Zeng, C., Yang, R., et al. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00968-8 · Cited by 21
Kjeldsen, S. A. S., Richter, M. M., Jensen, N. J., Nilsson, M., Heinz, N., Nybing, J. D., Linden, F. H., Høgh‐Schmidt, E., Boesen, M., Andersen, T. L., et al. (2024) · Diabetes · doi:10.2337/db23-0858 · Cited by 22
Peng, H., Xiang, J., Pan, L., Zhao, M., Chen, B., Huang, S., Yao, Z., Liu, J., & Lv, W. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01646-w · Cited by 22
Deery, H. A., Liang, E. X., Paolo, R. D., Voigt, K., Murray, G., Siddiqui, M. N., Egan, G. F., Moran, C., & Jamadar, S. D. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00019-0 · Cited by 19
Lu, J., Ni, J., Su, H., He, X., Lu, W., Zhu, W., Wang, Y., Ma, X., Bao, Y., & Zhou, J. (2024) · Diabetes · doi:10.2337/db24-0652 · Cited by 23
Sun, J., Meng, X., Guo, L., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02827-0 · Cited by 19
Retnakaran, R. R., Pu, J., Shen, J., Hanley, A. J., & Zinman, B. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00163-9 · Cited by 20
Adipose tissue redistribution caused by an early consumption of a high sucrose diet in a rat model.
Castellanos-Jankiewicz, A., Rodriguez-Peredo, S. M., Saldaña, G. C., Díaz, E. D., Tejero, M. E., del Bosque‐Plata, L., & Carbó, R. (2015) · PubMed · doi:10.3305/nh.2015.31.6.8935 · Cited by 19
Gidding, S. S., Palermo, R. A., DeLoach, S. S., Keith, S. W., & Falkner, B. E. (2013) · Pediatric Cardiology · doi:10.1007/s00246-013-0777-2 · Cited by 19
Hao, Y., Ma, X., Luo, Y., Hu, X., Pan, X., Xiao, Y., Bao, Y., & Jia, W. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4373 · Cited by 19
Shishido, T., Konta, T., Nishiyama, S., Miyashita, T., Miyamoto, T., Takasaki, S., Nitobe, J., Watanabe, T., Takeishi, Y., & Kubota, I. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531837 · Cited by 19
Barbieri, M., Boccardi, V., Esposito, A., Papa, M., Vestini, F., Rizzo, M. R., & Paolisso, G. (2011) · AGE · doi:10.1007/s11357-011-9210-z · Cited by 19
Fu, C.-P., Sheu, W., Lee, I., Lee, W.-J., Wang, J.-S., Liang, K.-W., Lee, W.-L., & Lin, S.-Y. (2015) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2014-0468 · Cited by 18
Jagannathan, R., Snehalatha, C., Selvam, S., Nanditha, A., Shetty, A. S., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0718-z · Cited by 19
Hypoadiponectinemia in Obesity: Association with Insulin Resistance
Prakash, J., Mittal, B., Awasthi, S., Agarwal, C. G., & Srivastava, N. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0246-3 · Cited by 20
Postprandial metabolism in adults with prader–willi syndrome
Purtell, L., Viardot, A., Sze, L., Loughnan, G., Steinbeck, K. S., Sainsbury, A., Herzog, H., Smith, A., & Campbell, L. V. (2015) · Obesity · doi:10.1002/oby.21041 · Cited by 19
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
